{"name":"Quigley Pharma, Inc.","slug":"quigley-pharma-inc","ticker":"","exchange":"","domain":"","description":"Quigley Pharma, Inc. is a biotechnology company focused on the development of innovative therapies. The company's lead candidate, QR-333, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNNGl6Z1g3VDdsQkxmWkZIdHVFSEFFVFVQYy1SVEFRem9hdjVXcGNRazlfa0xIQVlIa2xoYlJ5VnRzbTlUMlBEYi0tU1M2OHFENjZhYnhwbWxyYTNSU2I1Y0FIR004ZTY2RDNmY2JNX0dLWWZQdGFac2kxYllSSmFfRUMtSS04TlB0R1FMZkVmRUlxc1gwRGNzNWQ4V2YyaFJxSTZvcElLcHZtQVpVZjIxSmdMNFlzUQ?oc=5","date":"2025-11-05","type":"pipeline","source":"Investing.com","summary":"Terns Pharmaceuticals director sells $441k in stock - Investing.com","headline":"Terns Pharmaceuticals director sells $441k in stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQTTdvTFB4cW5SS25DR1p4MllkNk5QOHlkRWNNQ0xLbHQ5aXdfNGJ1QXhGRldOLV9sOW1ib1cwclZZTzJQTERxbkJRRmZvV0xUV2FRd2lSSFFySnV5WVhvNG8yRmVIT05yNTBFZ0NsU3VaeWxFYXR1UTN5ay1Ca05FZTVjV1J0M0ctWGpiOXZ1dkVYNzN2MGI1VWhpT1FSdGlNOWUzZ2t3OXNJR29paHd2MVh2XzgzaV9IZnk0enZEZEVkYUJqeHc?oc=5","date":"2025-09-15","type":"pipeline","source":"Business Post","summary":"Ireland faces tougher pharma investment battle as US tariffs bite, Inizio’s new boss warns - Business Post","headline":"Ireland faces tougher pharma investment battle as US tariffs bite, Inizio’s new boss warns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9fRHBxeXZtZ212NnRta1dIaVloQ3hOc2xQa3BMZEsxVG05MHBuWFhGaHpGaVhPUDdEYXk3N3ozZHNKTmNZMzVyMGhoYUtxbGctME1NTEpfT1BTWU1MOGhQQmp6N2JIWkxvX21iVUlWa3BIUnU5Y0FzYw?oc=5","date":"2025-09-12","type":"pipeline","source":"Barron's","summary":"Novartis Catches a ‘Sell.’ Goldman Sachs Says the Stock Is Overvalued. - Barron's","headline":"Novartis Catches a ‘Sell.’ Goldman Sachs Says the Stock Is Overvalued. - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQUG0wVGVyaVhNNzlVN3hnWUF3NF9zMmhiUXRxUkUxNTRPc291UWdzWXpfYjU3Qmo0ZmZETjF5WXdPTW9xeV9wRlFPSERZNmVNcjBORE5zaGpSVTdoMVpmVVp2T1FadEJBTV9SN3BsRjVvSDlIN2t1bVRIRWFvazBtci0yVEN4YTJNSWZWdHJrNF9QazNtamxvYTNQX1VOd2RUYnA3SVA1QWpmby16TTltVTd6Y0Q?oc=5","date":"2025-09-10","type":"pipeline","source":"Business Post","summary":"Dublin-based pharma services giant Inizio appoints Ryan Quigley as new boss - Business Post","headline":"Dublin-based pharma services giant Inizio appoints Ryan Quigley as new boss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOSENEcU1BaWQ3cmYtRVFCZU9GaWdDM1FGRk1KLTRiNm1qLVY0MjMtMmlWYkVHa1hlUUhIcGVkUFVQWFFUel9xbzBSMkJVazVIcnEzeW9FWWM5LTNmdEJzSDdQTkdBMmRmVTByTnJkdnlqeWRUODlVNDJ0WVhPeXQ5bWlmZw?oc=5","date":"2025-09-09","type":"pipeline","source":"Contract Pharma","summary":"Inizio Taps Ryan Quigley as CEO - Contract Pharma","headline":"Inizio Taps Ryan Quigley as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9UU0tqNGJRLXNQcEdTdTJWR3NaMGFQQ1ZZN3FHdEFnRGJsaERlSXFnQ1ZJd2hERUM5eDdzWGJ0OWtrZWZHcWxLVldkVkpOdHBLUnhvTUQxUGVQeXVUVE9GdUNWN1lBaU4zSG9WYkNnUQ?oc=5","date":"2025-09-09","type":"pipeline","source":"Medical Marketing and Media","summary":"Inizio names Ryan Quigley CEO - Medical Marketing and Media","headline":"Inizio names Ryan Quigley CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxQMFNmM0xHYktOd3hPdlVIYVBhM1I3UDRDeVRjeDZBWW5BZ1k2MTJJVUdSSXhPZmh2X29SUVhpUTNfdWJsU3V3cF9RQ2VfdGpVMXMwUmlfWXlIUzgteEY4bDFmNENoMW1IYTgtbnVaOTl4aUdadTQwTDhfZXA1NWxkSHF2bHg5RkdaTEhlNGFDQXEzLWdhNDdyay1YTURBUXFBTnU5WDlaei1CLWgxR2oyRmdYQ0M0U1dOOGFqX3B5eG84SWdody1RNUlQZmpwVkUydjVaOHRQaFFtdDVOQmtrc01wX0hZeDRYWlZmRzBzRFpwSUh3c3ZqRm1n?oc=5","date":"2025-04-10","type":"pipeline","source":"PR Newswire","summary":"Qnovia, Inc. Announces Leadership Transition and Strategic Appointments to Support UK Commercialization Strategy - PR Newswire","headline":"Qnovia, Inc. Announces Leadership Transition and Strategic Appointments to Support UK Commercialization Strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxPMEV5bF9QMzlSUkVtY0ttRGo3VDRIOEV5ejZNZzZjaVhhRFY3VjE1SUlybER2dTE3NFNUNjRWVkR6aHVJbHZPVzg3M2VPbEJYOHRVWGx5RXgtWUlqMl9mNEVRU0xha203S1pUcjlnREhhSUdPUS1CcDBDNldUQnAyUWYyN19UWW9YcVExdVZkVnNwNnY1UkRLZ0ZDLU5mVGViUHg2akRiZjltY05xSk9tazI0SmxJaE40ZzV3dWVROVFtS2tkbU1tbWd3dWs5ZmJKMDdpX0dsWEhLYVJnYkpSN0N6NFVHUS1PSHA2T3d6QWRoZF85S2tZc1k0N05CWWFHZ3pSckJxWEdDY0ExbkE?oc=5","date":"2024-12-10","type":"pipeline","source":"BioSpace","summary":"Qnovia, Inc. Raises $16 Million in Series B Financing to Advance Lead Asset RespiRx™ Nicotine Inhaler as a Prescription Smoking Cessation Therapy - BioSpace","headline":"Qnovia, Inc. Raises $16 Million in Series B Financing to Advance Lead Asset RespiRx™ Nicotine Inhaler as a Prescription ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5ka1VYRFd4RUhmb1doeHRKeGxHZVBRaTZubDR3Vnlub3RReUpKd2lWNXZJRks2VEtlcTFhZHNTOEZGRGRSV1FaNldtdk1qX0k4ZlprQzAxRE4xeXdTUVEzcXM1R2xOQnB4SXBaSS1TdjVSYWZodkZmcmQ3WQ?oc=5","date":"2024-10-01","type":"pipeline","source":"BioCentury","summary":"Sanofi names Mike Quigley CSO - BioCentury","headline":"Sanofi names Mike Quigley CSO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNZWNhdWRVUWZranlraU5BTDFnZkVWQWdZdTZITVUtaENBbk5qam9IZVRra1JfeGwzSFFiUFVDQWJQaDlwODZmZnRwUnJuOEc0UGpTcmdvd184a1FPa2ZjZ1BrNkQ4dE5jNjZkeThYM3QwSEx2SWZsRTFHNzlaQjd1QmlhYlRhRXBfNE43QkFIYmhpcDBMYVFlQ1ppUWVZU2lCczdjaW5oR2JnLXVGdjNBU3E5eDRrZw?oc=5","date":"2024-05-30","type":"deal","source":"Bloomberg.com","summary":"Goldman Sachs Says Buy European Pharma Stocks Touting Innovation - Bloomberg.com","headline":"Goldman Sachs Says Buy European Pharma Stocks Touting Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOb3V0SHZ4ZjludWJxZi1GRFlSejJtM2lJREZaNnlfVnhrWmdac09QeThFcFNOd1hWQVpCS1pOS21UMHFoRldGTGpOa2ZlWVFGM1dKdkRlMW1IZ1JXeC1MLVRpbGFjOTY3VmIyLVNqVXdrU0Rlb3BnVTItdEZwYlk5b2EzaTNxS0dwOTVtSVBfUm1WdW80SXp2NmNPX1drNjYyRXJ2ajZIRXZvUXlreTItbVNwYXotM0pzRWV0M2lFWEM3ZUJMMC11eHJiSXVzbTJuNTE0UWJDYkNPUUI5U2JDWHRLc3EwUQ?oc=5","date":"2022-08-18","type":"pipeline","source":"Business Wire","summary":"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO - Business Wire","headline":"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPcENqNUEzS2d1V0hYNkVIZkZ6RVdISlRzRkl2bVFLUVVGWVp3Mm1KUHQ0bUQ5WW8yNlM1eWQ2U0lyQ0FrN0h4MGpzWlhpaHB3Smd5dlZNTFdNT3J5RTA4VUJrMlBJZ2w5SXdVQTBKYlVzNzd2eXl5YXEwaTFHZjhxRXcteWF0QzZJck41QzNSWVZUZDFPVUg2bDNmVTk?oc=5","date":"2021-01-29","type":"pipeline","source":"McKinsey & Company","summary":"A new portfolio model for biotech - McKinsey & Company","headline":"A new portfolio model for biotech - McKinsey & Company","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}